Medprin Regenerative Medical Technologies Co. Ltd. (301033) — Free Cash Flow Generation Index
Medprin Regenerative Medical Technologies Co. Ltd. (301033) has a Free Cash Flow Generation Index of 0.72x as of December 2024. Free cash flow of CN¥83.22 Million represents 1% of operating cash flow (CN¥116.38 Million). Read Medprin Regenerative Medical Technologie total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Medprin Regenerative Medical Technologies Co. Ltd. Free Cash Flow Generation Index (2019–2024)
Historical FCF Generation Index trend for Medprin Regenerative Medical Technologies Co. Ltd. across 6 annual periods. Explore Medprin Regenerative Medical Technologie (301033) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Medprin Regenerative Medical Technologies Co. Ltd. (2019–2024)
Year-by-year Free Cash Flow Generation Index for Medprin Regenerative Medical Technologies Co. Ltd.. For the full company profile including market capitalisation, see how much is Medprin Regenerative Medical Technologie worth.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.72x | CN¥83.22 Million | CN¥116.38 Million | CN¥33.16 Million | ▲ +13.9% |
| 2023 | 0.63x | CN¥67.60 Million | CN¥107.69 Million | CN¥40.09 Million | ▲ +134.6% |
| 2022 | -1.81x | CN¥-87.65 Million | CN¥48.31 Million | CN¥135.96 Million | ▼ -40.0% |
| 2021 | -1.30x | CN¥-86.20 Million | CN¥66.51 Million | CN¥152.71 Million | ▼ -58.4% |
| 2020 | -0.82x | CN¥-27.74 Million | CN¥33.91 Million | CN¥61.65 Million | ▼ -370.6% |
| 2019 | -0.17x | CN¥-5.44 Million | CN¥31.27 Million | CN¥36.71 Million | — |